Anthony P. Ford
Gründer bei Afferent Pharmaceuticals, Inc.
Profil
Anthony P.
Ford is the founder of Afferent Pharmaceuticals, Inc. (founded in 2009) and holds the title of Chief Scientific Officer.
He is currently the Director at PharmNovo AB (since 2018).
In the past, he worked as Vice President-Research at Roche Holdings, Inc. and Syntex, Inc. Dr. Ford obtained a doctorate degree from The University of Nottingham.
Aktive Positionen von Anthony P. Ford
| Unternehmen | Position | Beginn |
|---|---|---|
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Gründer | 17.12.2009 |
PharmNovo AB
 PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | 01.01.2018 |
Ehemalige bekannte Positionen von Anthony P. Ford
| Unternehmen | Position | Ende |
|---|---|---|
| Syntex, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anthony P. Ford
| The University of Nottingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Health Technology |
Roche Holdings, Inc.
Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Finance |
| Syntex, Inc. | Miscellaneous |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Commercial Services |
